云南白药、654-2外用辅治新生儿硬肿症

The anxilliary treatment effect of Yunnan White Drug and 654-2 on the neonates scleredema

目的:评价云南白药与654-2混合外用对新生儿硬肿症的辅助治疗作用。方法:将住院病人分为治疗组和对照组,治疗组除常规治疗外外用云南白药和654-2混合制剂,对照组常规治疗。比较两组的治愈率和临床表现。结果:治疗组与对照组在治愈率上无显著差异(P>0.05),但在体温回升时间、硬肿消退时间和住院时间等临床表现方面具有明显优势(P<0.05)。结论:云南白药与654-2外用辅助治疗新生儿硬肿症可明显改善临床体征,提高患儿的生存状况。

Objective: To evaluate the anxilliary treatment effect of Yunnan White Drug and 654 2 on neonates scleredema. Methods: Inpatients were divided into treatment and control groups. The treatment group were treated with mixture of Yunan White Drug and 654 2 external used in addition to the routine treatment. while the control group were treated only routinely. And then the cure rate and clinical manifestation were compared. Results: Though the cure rate of two groups were no significantly different(P >0.05), the thermo-resuming-time, sclero-subsiolising-time and hospitalization of the treatment group were apparent shorter than that of the control group(P< 0.05). Conclusion: Clinical sign in neonates with this disease can be significantly improved by Yunnan White Drug and 654 2 externally used, therefore their viability was enhanced.